Featured Speakers
Keynotes
Luncheon Keynote
Robert J. Hugin
Chairman and CEO
Celgene Corporation
Morning Keynotes
Andre Wyss
US Country Head, President
Novartis Corporation and
President
Novartis Pharmaceuticals Corporation
John F. Crowley
Chairman and CEO
Amicus Therapeutics, Inc.
Afternoon Keynote
Tony Gibney
Managing Director
Leerink Swann LLC
Reception, Dinner and Fireside Chat on the Evening of Thursday, October 3
(By invitation only)
Dominic J. Caruso
Vice President of Finance and CFO
Johnson & Johnson
Presenting Companies
Will Lewis
President and CEO
Insmed Incorporated
David Pearson, Ph.D.
President
Thrombogenics, Inc.
Spiro Rombotis
President and CEO
Cyclacel Pharmaceuticals, Inc.
Panelists and Moderators
In the Trenches with Tranches: Financing Strategies for Growth
Lorenzo Pellegrini, Ph.D.
Partner
Care Capital, LLC
Stuart Peltz, Ph.D.
CEO
PTC Therapeutics, Inc.
Chris Tyrrell
CEO
OfferBoard
Michael Wells
Managing Director
Princeton Biopharma Capital Partners LLC
Moderator:
James Marino, Esq.
Partner
Dechert LLP
Inside Outsourcing
John Barry
Global Head, Vendor Management for Development
Merck & Co., Inc.
Sally Macaluso
Vice President, Janssen R&D Procurement
Johnson & Johnson
Ralph Marcello
Principal
Deloitte
Raymond Hill
President
inVentiv Health Clinical
John Watson
Corporate Senior Vice President, President, Strategic Partnering and Chief Commercial Officer
Covance Inc.
Moderator:
John Fraher
President
Aptalis Pharma
How Wide is the Crack in the IPO Window?
Kenneth I. Moch
President and CEO
Chimerix, Inc.
Christian S. Schade
Executive Vice President and CFO
Omthera Pharmaceuticals, Inc.
Panna Sharma
President and CEO
Cancer Genetics, Inc.
Moderator:
Hector G. Calzada, Jr.
Managing Director
Deloitte Corporate Finance LLC
Billion Dollar Babies
Anthony Marucci
Founder, President and CEO
Celldex Therapeutics , Inc.
Francois Nader, M.D.
President and CEO
NPS Pharmaceuticals, Inc.
Glenn Sblendorio
President and CFO
The Medicines Company
Moderator:
Julie Kampf
CEO and President
JBK Associates International